Name | Title | Contact Details |
---|---|---|
Lauren Hart |
Associate Director, HCP Marketing | Profile |
Ben Halladay |
Chief Financial Officer | Profile |
Stephen Pinkosky |
Senior Director, R&D | Profile |
Andrew Bramble |
Sr. Manager, Drug Product Technical Services | Profile |
Marianne Andreach |
Senior Vice President, Product Planning | Profile |
Nvision is a medical device and biologics company focusing on providing surgeons with implants and biologics that simplify and improve surgery procedures.
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.
Lucid Hearing hearing aids are affordable and ensure that you hear what you need to hear when you need to hear it. Come to one of our 500+ hearing centers nationwide and receive a free hearing test today.
Ecopia BioSciences Inc. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cychem, Inc. is a Westlake Village, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.